PG
Pramila Gupta
About Pramila Gupta
Data last updated:
Pramila Gupta has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Axonwave Pharmaceuticals Private Limited and Delhi Epilepsy And Stroke Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Axonwave Pharmaceuticals Private Limited at ₹39.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Oct 2020 | 2020 | ₹39.8 Lakh (FY 2025) | Active | |
| Director | 20 May 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramila Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramila Gupta
Pramila Gupta has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Axonwave Pharmaceuticals Private Limited and Delhi Epilepsy And Stroke Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Axonwave Pharmaceuticals Private Limited at ₹39.8 Lakh (FY 2025).
Pramila Gupta is associated with 2 companies as Director, including Axonwave Pharmaceuticals Private Limited (₹39.8 Lakh), Delhi Epilepsy And Stroke Foundation.
Pramila Gupta has expertise in General Business.
Pramila Gupta has 5 years in corporate governance.
By reported revenue, the largest current company of Pramila Gupta is Axonwave Pharmaceuticals Private Limited, with revenue of ₹39.8 Lakh (FY 2025).
Pramila Gupta currently holds positions at 2 companies: Axonwave Pharmaceuticals Private Limited (₹39.8 Lakh), Delhi Epilepsy And Stroke Foundation.